Active ingredientTelaprevirCat. No. P-T037-001CAS 402957-28-2Family · Pharmaceutical analytical standards
Telaprevir
An antiviral that blocks the NS3/4A protease of the hepatitis C virus, approved in the United States in 2011 for chronic genotype 1 hepatitis C together with peginterferon and ribavirin; production ended in 2014, as newer therapies took over. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?The FDA approved it on 23 May 2011, just ten days after boceprevir: the two NS3 protease inhibitors opened the era of medicines that directly hit an enzyme of the hepatitis C virus.
Go to the active ingredient →Active ingredientTelaprevirCat. No. P-T037-001CAS 402957-28-2
Isotopically labelledTelaprevir-d4Cat. No. P-T037-002
ImpurityTelaprevir Impurity 1Cat. No. P-T037-003CAS 1616728-72-3No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.